62 related articles for article (PubMed ID: 31178204)
1. Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence.
Choi WR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jul; 94():106-110. PubMed ID: 31178204
[TBL] [Abstract][Full Text] [Related]
2. The significance and prognostic value of multifocal papillary thyroid carcinoma in children and adolescents.
Sun Y; Liu Y; Li H; Tang Y; Liu W; Zhang Y; Yin D
BMC Cancer; 2024 Jun; 24(1):690. PubMed ID: 38844891
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Tumor Multifocality in Pediatric Papillary Thyroid Carcinoma: A Real-Life Multicentric Study.
Xu Y; Shi L; Wu J; Li H; Wang Y; Liu B
Otolaryngol Head Neck Surg; 2023 Dec; 169(6):1606-1614. PubMed ID: 37222185
[TBL] [Abstract][Full Text] [Related]
4. Unilateral Multifocality and Bilaterality Could Be Two Different Multifocal Entities in Patients with Papillary Thyroid Microcarcinoma.
Cai J; Fang F; Chen J; Xiang D
Biomed Res Int; 2020; 2020():9854964. PubMed ID: 32714990
[TBL] [Abstract][Full Text] [Related]
5. Bilaterality as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma.
Kim H; Kwon H
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001674
[TBL] [Abstract][Full Text] [Related]
6. A quantitative assessment of the number of disease foci in papillary thyroid cancer.
Evans Harding N; Simo R; Li L; Maniam P; Adamson R; Hay A; Conn B; Lyall M; Nixon IJ
Eur J Surg Oncol; 2023 Jul; 49(7):1141-1146. PubMed ID: 37024371
[TBL] [Abstract][Full Text] [Related]
7. A novel risk stratification model based on tumor size and multifocality to predict recurrence in pediatric PTC: comparison with adult PTC.
Du R; Zhang Y; Kou J; Li J; Sui C; Zhang D; Fu Y; Zhou L; Fu Q; Li F; Dionigi G; Liang N; Sun H
Front Endocrinol (Lausanne); 2023; 14():1298036. PubMed ID: 38274235
[TBL] [Abstract][Full Text] [Related]
8. Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
Scholfield DW; Lopez J; Eagan A; Antal Z; Tuttle RM; Ghossein R; LaQuaglia M; Shaha AR; Shah JP; Wong RJ; Patel SG; Ganly I
J Clin Endocrinol Metab; 2023 Nov; 108(12):3135-3144. PubMed ID: 37350510
[TBL] [Abstract][Full Text] [Related]
9. PD-L1 Expression and Ultrasound Characteristics in Papillary Thyroid Carcinoma and Its Effect on Recurrence.
Li R; Li M; Sun B; Qi M; Peng C; Li H; Zheng S; Liu Q; Jiang C
In Vivo; 2023; 37(6):2820-2828. PubMed ID: 37905619
[TBL] [Abstract][Full Text] [Related]
10. Lack of Associations between Body Mass Index and Clinical Outcomes in Patients with Papillary Thyroid Carcinoma.
Kwon H; Kim M; Choi YM; Jang EK; Jeon MJ; Kim WG; Kim TY; Shong YK; Song DE; Baek JH; Hong SJ; Kim WB
Endocrinol Metab (Seoul); 2015 Sep; 30(3):305-11. PubMed ID: 25433662
[TBL] [Abstract][Full Text] [Related]
11. Extent of surgery for unilateral papillary thyroid cancer with nonsuspicious contralateral nodules by ultrasound.
Xu S; Huang H; Xian K; Wang X; Xu Z; Liu S; Liu J
Endocrine; 2024 May; ():. PubMed ID: 38703328
[TBL] [Abstract][Full Text] [Related]
12. Papillary Thyroid Cancer Trends in the Wake of the COVID-19 Pandemic: Is There a Shift toward a More Aggressive Entity?
Hassan I; Hassan L; Bacha F; Al Salameh M; Gatee O; Hassan W
Diseases; 2024 Mar; 12(3):. PubMed ID: 38534986
[TBL] [Abstract][Full Text] [Related]
13. MET-receptor targeted fluorescent imaging and spectroscopy to detect multifocal papillary thyroid cancer.
Metman MJH; Jonker PKC; Sondorp LHJ; van Hemel BM; Sywak MS; Gill AJ; Jansen L; van Diest PJ; van Ginhoven TM; Löwik CWGM; Nguyen AH; Robinson DJ; van Dam GM; Links TP; Coppes RP; Fehrmann RSN; Kruijff S
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2384-2394. PubMed ID: 38017325
[TBL] [Abstract][Full Text] [Related]
14. PREDICTORS OF MULTIFOCAL PAPILLARY THYROID CANCER. DO THEY EXIST?
Mazur OV; Palamarchuk VA; Tovkai OA; Kuts VV; Shidlovskyi VO; Sheremet MI; Levchuk RD; Morozovych II; Lazaruk OV; Cretoiu D
Acta Endocrinol (Buchar); 2022; 18(4):424-428. PubMed ID: 37152890
[TBL] [Abstract][Full Text] [Related]
15. Retracted: Unilateral Multifocality and Bilaterality Could Be Two Different Multifocal Entities in Patients with Papillary Thyroid Microcarcinoma.
International BR
Biomed Res Int; 2024; 2024():9875768. PubMed ID: 38550014
[TBL] [Abstract][Full Text] [Related]
16. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
17. Shear wave elastography combined with gray-scale ultrasound for predicting central lymph node metastasis of papillary thyroid carcinoma.
Li T; Li H; Xue J; Miao J; Kang C
Surg Oncol; 2021 Mar; 36():1-6. PubMed ID: 33271464
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for posttreatment recurrence in patients with intermediate-risk papillary thyroid carcinoma.
Kim Y; Roh JL; Song DE; Cho KJ; Choi SH; Nam SY; Kim SY
Am J Surg; 2020 Sep; 220(3):642-647. PubMed ID: 32035626
[TBL] [Abstract][Full Text] [Related]
19. Thermal ablation for multifocal papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Zhang J; Liu J; Yi W; Liu Y; Liu Y; Xu J
Endocrine; 2024 Feb; ():. PubMed ID: 38319587
[TBL] [Abstract][Full Text] [Related]
20. Course and predictors of excellent response to therapy in patients with differentiated thyroid cancer at long-term follow-up.
Samargandy SA; Qorban GN; Aljadani AK; Almufarji SS; Azab AM; Merdad MA; Al-Hajeili MR; Samargandy SJ
Saudi Med J; 2024 Feb; 45(2):139-146. PubMed ID: 38309729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
